Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry. - Rob, Filip; Gkalpakiotis, Spyridon; Kojanová, Martina; Vantuchová, Yvetta; Čelakovská, Jarmila; Horažďovský, Jiří; Baláž, Monika; Nečas, Miroslav; Stuchlík, David; Cetkovská, Petra; Hrazdírová, Kateřina; Machovcová, Alena; et al. (Journal of the European Academy of Dermatology & Venereology, 2025)